Amerise Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2025 ,inter alia, to consider and approve PFA
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Amerise Biosciences Ltd (formerly Amradeep Industries Ltd) has informed BSE that its Board of Directors will meet on Wednesday, 5 November 2025. The main agenda is to consider and approve the Un-Audited Financial Results for the quarter and half year ended 30 September 2025 (i.e., Q2 FY26 results). The intimation is filed under Regulation 29 of SEBI (LODR) Regulations, 2015. Director Dineshkumar Tribhovandas Rathod has signed the communication dated 30 October 2025. No other specific business items have been disclosed beyond a general 'any other matter' clause.
This is a routine compliance filing ahead of the Q2 FY26 earnings announcement. Investors should watch for the actual results on or after 5 November 2025 to assess the company's financial performance; the filing itself has no direct impact on the stock price.